These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18691414)

  • 1. Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands.
    Dai W; Teodoridis JM; Graham J; Zeller C; Huang TH; Yan P; Vass JK; Brown R; Paul J
    BMC Bioinformatics; 2008 Aug; 9():337. PubMed ID: 18691414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
    Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
    Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
    Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
    PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
    Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance.
    Sung HY; Han J; Chae YJ; Ju W; Lee Kang J; Park AK; Ahn JH
    BMB Rep; 2023 Jun; 56(6):347-352. PubMed ID: 37013346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
    Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
    Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis.
    Yamashita S; Hosoya K; Gyobu K; Takeshima H; Ushijima T
    DNA Res; 2009 Oct; 16(5):275-86. PubMed ID: 19767598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profiling of CpG islands in human breast cancer cells.
    Huang TH; Perry MR; Laux DE
    Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
    Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K
    Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyribonucleic acid methylation profiling of single human blastocysts by methylated CpG-island amplification coupled with CpG-island microarray.
    Huntriss J; Hemmings K; Baskaran P; Hazelwood L; Elder K; Virtanen C; Miller D; Picton HM
    Fertil Steril; 2015 Jun; 103(6):1566-71.e1-4. PubMed ID: 25914096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring methylation changes in cancer.
    Beier V; Mund C; Hoheisel JD
    Adv Biochem Eng Biotechnol; 2007; 104():1-11. PubMed ID: 17290816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying hypermethylated CpG islands using a quantile regression model.
    Sun S; Chen Z; Yan PS; Huang YW; Huang TH; Lin S
    BMC Bioinformatics; 2011 Feb; 12():54. PubMed ID: 21324121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
    Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
    Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential methylation hybridization: profiling DNA methylation with a high-density CpG island microarray.
    Yan PS; Potter D; Deatherage DE; Huang TH; Lin S
    Methods Mol Biol; 2009; 507():89-106. PubMed ID: 18987809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation.
    Yan PS; Efferth T; Chen HL; Lin J; Rödel F; Fuzesi L; Huang TH
    Methods; 2002 Jun; 27(2):162-9. PubMed ID: 12095276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
    Nogales V; Reinhold WC; Varma S; Martinez-Cardus A; Moutinho C; Moran S; Heyn H; Sebio A; Barnadas A; Pommier Y; Esteller M
    Oncotarget; 2016 Jan; 7(3):3084-97. PubMed ID: 26625211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.